ProGlyTM

Imagine a world where we are can reeducate the immune system to help patients live better lives

The ProGly platform chemistry comprises glycan-containing NSAAs that can induce or inhibit an immune reaction. The GRO platform enables precise placement of defined ProGly compositions on the protein surface necessary to elicit a defined immune response. The Company’s first ProGly NSAAs reeducate the immune system to treat a protein as “self” or “non-self” — a totally new modality for eliminating autoimmunity and anti-drug antibodies.